Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Hercessi™ (trastuzumab-strf) – New biosimilar approval

April 29, 2024 - Accord BioPharma announced the FDA approval of Hercessi (trastuzumab-strf), biosimilar to Genentech’s Herceptin® (trastuzumab).

Download PDF

 

Rx navigation